American Journal of Kidney Diseases

The American Journal of Kidney Diseases is the monthly peer-reviewed journal of the National Kidney Foundation, published by Elsevier, which has been a leading source of clinical nephrology research and practice since it was first published in 1981 and carried a 2025 Journal Impact Factor of 9.4《美国肾脏病杂志》（American Journal of Kidney Diseases）是美国国家肾脏基金会（National Kidney Foundation）的月刊型同行评审期刊，由（Elsevier）出版，自 1981 年创刊以来一直是临床肾脏病研究与实践的权威信息来源，2025 年影响因子为 9.4。

Scope

• The journal is devoted to clinical nephrology research and practice and is recognized worldwide as a leading source of information in the specialty该刊专注于临床肾脏病的研究与实践，被公认为全球范围内该专科的重要信息来源。
• Topics span the pathogenesis and treatment of kidney disease, hypertension, acid-base and electrolyte disorders, dialysis therapies, kidney transplantation and patient-centered outcomes主题涵盖肾脏病的发病机制与治疗、高血压、酸碱与电解质紊乱、透析疗法、肾移植以及以患者为中心的结局。
• It also covers health care policy, the socioeconomic aspects of kidney disease and treatment, and health care disparities该刊亦涵盖卫生政策、肾脏病及其治疗的社会经济层面以及医疗不平等问题。
• Content includes original research, reviews, editorials, case reports and human interest pieces, with laboratory studies considered only when directly linked to human measurements or outcomes内容体裁包括原创研究、综述、社论、病例报告与人文类文章，实验室研究仅在与人体测量或结局直接相关时才予考虑。
• Articles undergo rigorous peer review and editorial consideration, including statistical review where appropriate, and the stated review criteria are validity, clinical importance and interest文章须经严格的同行评审与编辑审查，必要时进行统计学审查，官方列出的评审标准为有效性、临床重要性与受关注度。
• It is indexed in MEDLINE and PubMed, the Science Citation Index Expanded and Scopus, holding the first quartile in the Urology and Nephrology category with a rank of 7 out of 134 titles该刊被（MEDLINE）与（PubMed）、（Science Citation Index Expanded）及（Scopus）收录，在泌尿与肾脏病学类位居第一四分位，于 134 种刊中排名第 7 位。

History

• The journal was first published in 1981, when its first volume opened in July 1981, and it is the official journal of the National Kidney Foundation该刊于 1981 年创刊，首卷于 1981 年 7 月推出，是（National Kidney Foundation）的机关刊。
• It is published by Elsevier under the W.B. Saunders imprint, with recent article deposits carrying the 10.1053 DOI prefix该刊由（Elsevier）以其（W.B. Saunders）品牌出版，近年文章使用 10.1053 号（DOI）前缀。
• Two six-issue volumes appear each year under monthly publication, and the journal reached volume 88 in 2026该刊每月出版，每年两卷各 6 期，至 2026 年已出到第 88 卷。
• Its Journal Impact Factor stood at 8.86 in 2021 and 11.072 in 2022, was 8.2 in 2024 and reached 9.4 in 2025其影响因子 2021 年为 8.86、2022 年为 11.072、2024 年为 8.2，2025 年升至 9.4。
• A first-issue article published in July 1981 linked parathyroid hormone to post-transplant blood pressure regulation1981 年 7 月首期的一篇文章报道了甲状旁腺激素与移植后血压调节的关联。^[1]

Editors

• Harold I. Feldman is the editor-in-chief and has been reappointed for a second term, based at the University of Pennsylvania in Philadelphia（Harold I. Feldman）任主编，已获连任进入第二个任期，任职于费城的宾夕法尼亚大学。
• Jeffrey S. Berns is a deputy editor, based at the University of Pennsylvania in Philadelphia（Jeffrey S. Berns）任副主编，任职于费城的宾夕法尼亚大学。
• Laura M. Dember is a deputy editor, also based at the University of Pennsylvania in Philadelphia（Laura M. Dember）任副主编，同样任职于费城的宾夕法尼亚大学。
• Holly J. Mattix-Kramer is the engagement editor, based at Loyola University Medical Center in Maywood, Illinois（Holly J. Mattix-Kramer）任互动编辑，任职于伊利诺伊州梅伍德的洛约拉大学医学中心。
• Wolfgang C. Winkelmayer has been named the next editor-in-chief, with his term beginning on 1 January 2027（Wolfgang C. Winkelmayer）已被任命为下一任主编，任期自 2027 年 1 月 1 日起。
• The National Kidney Foundation appoints the editor-in-chief, and manuscripts are reviewed through the journal's editorial board主编由（National Kidney Foundation）任命，稿件由该刊编辑委员会组织评审。